Life Science Investing Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing
Life Science Investing Veracyte Announces that Decipher-Enabled Biomarker Predicts Hormone Therapy Benefit in Men with Recurrent Prostate Cancer
Life Science Investing Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025
Life Science Investing Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting
Rio Silver Provides Corporate Update as the Company Advances Toward High-Grade Silver Development in Peru
Surface Metals Inc. Confirms Open Mineralization and Expansion Potential at Cimarron Gold Project, Nevada
SAGA Metals Completes First Cross Section Through Extensive Oxide Layer in Trapper Zone at Radar Project in Labrador
